Search Results

There are 75668 results for: content related to: Delay to institution of therapy and induction of remission using single-drug or combination–disease-modifying antirheumatic drug therapy in early rheumatoid arthritis

  1. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  2. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  3. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  4. You have free access to this content
    Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: Five-year experience from the FIN-RACo study

    Arthritis & Rheumatism

    Volume 50, Issue 7, July 2004, Pages: 2072–2081, Markku Korpela, Leena Laasonen, Pekka Hannonen, Hannu Kautiainen, Marjatta Leirisalo-Repo, Markku Hakala, Leena Paimela, Harri Blåfield, Kari Puolakka and Timo Möttönen

    Version of Record online : 6 JUL 2004, DOI: 10.1002/art.20351

  5. You have free access to this content
    The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: The eleven-year results of the Finnish rheumatoid arthritis combination therapy trial

    Arthritis & Rheumatism

    Volume 60, Issue 5, May 2009, Pages: 1222–1231, Vappu Rantalaiho, Markku Korpela, Pekka Hannonen, Hannu Kautiainen, Salme Järvenpää, Marjatta Leirisalo-Repo, Markku Hakala, Kari Puolakka, Heikki Julkunen, Riitta Luosujärvi, Timo Möttönen and FIN-RACo Trial Group

    Version of Record online : 29 APR 2009, DOI: 10.1002/art.24447

  6. You have free access to this content
    ACR/ARHP scientific abstracts

    Arthritis & Rheumatism

    Volume 42, Issue S9, September 1999, Pages: S71–S407,

    Version of Record online : 9 MAY 2012, DOI: 10.1002/art.1780422107

  7. You have free access to this content
    Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: A five-year randomized followup trial

    Arthritis & Rheumatism

    Volume 50, Issue 1, January 2004, Pages: 55–62, Kari Puolakka, Hannu Kautiainen, Timo Möttönen, Pekka Hannonen, Markku Korpela, Heikki Julkunen, Reijo Luukkainen, Kaisa Vuori, Leena Paimela, Harri Blåfield, Markku Hakala and Marjatta Leirisalo-Repo

    Version of Record online : 9 JAN 2004, DOI: 10.1002/art.11436

  8. You have free access to this content
    Program Overview

    Arthritis & Rheumatism

    Volume 39, Issue S9, September 1996, Pages: S27–S325,

    Version of Record online : 12 DEC 2005, DOI: 10.1002/art.1780391402

  9. You have free access to this content
    Etanercept for the treatment of rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Anne Lethaby, Maria Angeles Lopez-Olivo, Lara J Maxwell, Amanda Burls, Peter Tugwell and George A Wells

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD004525.pub2

  10. Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Ahmed Kotb, Robin Christensen, Amy S Mudano, Lara J Maxwell, Nipam P Shah, Peter Tugwell and George A Wells

    Published Online : 13 MAY 2016, DOI: 10.1002/14651858.CD012183

  11. You have free access to this content
    Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations

    Arthritis & Rheumatism

    Volume 43, Issue 11, November 2000, Pages: 2397–2401, Marko H. Neva, Markku J. Kauppi, Hannu Kautiainen, Reijo Luukkainen, Pekka Hannonen, Marjatta Leirisalo-Repo, Martti Nissilä and Timo Möttönen

    Version of Record online : 26 MAR 2001, DOI: 10.1002/1529-0131(200011)43:11<2397::AID-ANR4>3.0.CO;2-V

  12. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA)

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Amy S Mudano, Peter Tugwell and George A Wells

    Published Online : 17 NOV 2016, DOI: 10.1002/14651858.CD012437

  13. Impaired Akt Phosphorylation in Monocytes of Patients with Rheumatoid Arthritis

    Scandinavian Journal of Immunology

    Accepted manuscript online: 19 DEC 2016, Krista Kuuliala, Antti Kuuliala, Mari Hämäläinen, Riitta Koivuniemi, Hannu Kautiainen, Eeva Moilanen, Heikki Repo and Marjatta Leirisalo-Repo

    DOI: 10.1111/sji.12521

  14. You have free access to this content
    Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: Five-year experience from the FIN-RACo trial

    Arthritis & Rheumatism

    Volume 52, Issue 1, January 2005, Pages: 36–41, Kari Puolakka, Hannu Kautiainen, Timo Möttönen, Pekka Hannonen, Markku Korpela, Markku Hakala, Pentti Järvinen, Jari Ahonen, Sinikka Forsberg and Marjatta Leirisalo-Repo

    Version of Record online : 7 JAN 2005, DOI: 10.1002/art.20716

  15. You have free access to this content
    Arthritis & Rheumatism, 2001 Annual Scientific Meeting Abstracts, November 10–15, 2001, San Francisco, CA

    Arthritis & Rheumatism

    Volume 44, Issue S9, September 2001, Pages: 277–390,

    Version of Record online : 22 FEB 2002, DOI: 10.1002/1529-0131(200109)44:9+<::AID-ART427>3.0.CO;2-4

  16. You have free access to this content
    Aurothiomalate inhibits cyclooxygenase 2, matrix metalloproteinase 3, and interleukin-6 expression in chondrocytes by increasing MAPK phosphatase 1 expression and decreasing p38 phosphorylation: MAPK phosphatase 1 as a novel target for antirheumatic drugs

    Arthritis & Rheumatism

    Volume 62, Issue 6, June 2010, Pages: 1650–1659, Riina Nieminen, Riku Korhonen, Teemu Moilanen, Andrew R. Clark and Eeva Moilanen

    Version of Record online : 22 FEB 2010, DOI: 10.1002/art.27409

  17. You have free access to this content
    Brief Report: Main Contribution of DRB1*04:05 Among the Shared Epitope Alleles and Involvement of DRB1 Amino Acid Position 57 in Association With Joint Destruction in Anti–Citrullinated Protein Antibody–Positive Rheumatoid Arthritis

    Arthritis & Rheumatology

    Volume 67, Issue 7, July 2015, Pages: 1744–1750, Chikashi Terao, Koichiro Yano, Katsunori Ikari, Moritoshi Furu, Noriyuki Yamakawa, Shinji Yoshida, Motomu Hashimoto, Hiromu Ito, Takao Fujii, Koichiro Ohmura, Kimiko Yurugi, Yasuo Miura, Taira Maekawa, Atsuo Taniguchi, Shigeki Momohara, Hisashi Yamanaka, Tsuneyo Mimori and Fumihiko Matsuda

    Version of Record online : 26 JUN 2015, DOI: 10.1002/art.39105

  18. You have free access to this content
    Efficacy of combination therapy in rheumatoid arthritis: Comment on the review by Smolen et al

    Arthritis & Rheumatism

    Volume 54, Issue 6, June 2006, Pages: 2032–2034, Timo Möttönen, Pekka Hannonen, Marjatta Leirisalo-Repo, Markku Korpela, Markku Hakala, Hannu Kautiainen and FIN-RACo Trial Group

    Version of Record online : 26 MAY 2006, DOI: 10.1002/art.21915

  19. You have free access to this content
    A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine

    British Journal of Clinical Pharmacology

    Volume 79, Issue 5, May 2015, Pages: 777–788, Jessica Wojciechowski, Michael D. Wiese, Susanna M. Proudman, David J. R. Foster and Richard N. Upton

    Version of Record online : 22 APR 2015, DOI: 10.1111/bcp.12553

  20. Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma

    European Journal of Haematology

    Volume 51, Issue 2, August 1993, Pages: 98–101, I. P. Palva, K. Ala-Harja, A. Almqvist, E. Elonen, H. Hallman, A. Hänninen, M. Ilvonen, B. Isomaa, J. Jouppila, E. Järvenpáá, G. Järventie, H. Kilpi, P. Koistinen, E. Koivunen, K. Kátká, M. Kááriáinen, R. Lahtinen, A. Laitinen, M. Lehtinen, H. Mäkelä, P. Nyländen, D. Nyman, T. Oivanen, T-T. Pelliniemi, T. Pulli, A. Rajamäki, K. Remes, S. Rosengård, T. Ruutu, K. Soininen, T. Timonen, C. Wasastjerna, J. Vilpo and L. Volin

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1993.tb01600.x